hospital covid-19 patient

A mysterious company’s coronavirus papers in top medical journals may be unraveling

Reading now: 392
www.sciencemag.org

A hydroxychloroquine study is being audited. By Kelly Servick, Martin EnserinkScience's COVID-19 reporting is supported by the Pulitzer Center.On its face, it was a major finding: Antimalarial drugs touted by the White House as possible COVID-19 treatments looked to be not just ineffective, but downright deadly.

A study published on 22 May in The Lancet used hospital records procured by a little-known data analytics company called Surgisphere to conclude that coronavirus patients taking chloroquine or hydroxychloroquine were more likely to show an irregular heart rhythm—a known side effect thought to be rare—and were more likely to die in the hospital.Within days, some large randomized trials of the drugs—the type that might prove or

Read more on sciencemag.org
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA